New Stock News | Bangshun Pharmaceuticals Hong Kong IPO Prospectus Invalid

According to the Wisdom Financial APP, the Hong Kong IPO prospectus submitted by Hangzhou Bangshun Pharmaceutical Co., Ltd. (referred to as Bangshun Pharmaceutical) on January 22, 2026, will expire after 6 months on July 22, 2026. Citic Securities International is its exclusive sponsor.